Zafar, S., Sorsa, S., Siurala, M., Hemminki, O., Havunen, R., Cervera-Carrascon, V., . . . Hemminki, A. (2018). CD40L coding oncolytic adenovirus allows long-term survival of humanized mice receiving dendritic cell therapy. Oncoimmunology.
Citação norma ChicagoZafar, Sadia, et al. "CD40L Coding Oncolytic Adenovirus Allows Long-term Survival of Humanized Mice Receiving Dendritic Cell Therapy." Oncoimmunology 2018.
MLA CitationZafar, Sadia, et al. "CD40L Coding Oncolytic Adenovirus Allows Long-term Survival of Humanized Mice Receiving Dendritic Cell Therapy." Oncoimmunology 2018.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.